NL
BHVN

NVWM LLC’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

NVWM LLC’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,208
Closed -$855K – 563
2022
Q1 		$855K Sell
7,208
-3,057
-30% -$381K 0.27% 129
2021
Q4 		$1.41M Buy
10,265
+219
+2% +$27.8K 0.44% 69
2021
Q3 		$1.39M Sell
10,046
-2,575
-20% -$322K 0.5% 51
2021
Q2 		$1.23M Sell
12,621
-105
-0.8% -$8.52K 0.44% 65
2021
Q1 		$870K Sell
12,726
-163
-1% -$13.2K 0.35% 109
2020
Q4 		$1.1M Buy
12,889
+197
+2% +$16.7K 0.46% 69
2020
Q3 		$825K Buy
12,692
+150
+1% +$9.83K 0.39% 88
2020
Q2 		$917K Buy
12,542
+6,190
+97% +$329K 0.49% 63
2020
Q1 		$216K Buy
+6,352
New +$290K 0.15% 131

Other funds holding BHVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NVWM LLC's BHVN Position: Q2 2022 in Review

NVWM LLC sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2022, closing a stake of 7,208 shares — an estimated $855K sold.

NVWM LLC first reported a position in BHVN in Q1 2020 and held it in 9 quarters. The position peaked at $1.41M in Q4 2021. 329 funds tracked by Wall St. Rank hold BHVN as of Q2 2022.

  • NVWM LLC reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2022 after selling out during the quarter.
  • NVWM LLC sold 7,208 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2022, an estimated $855K.
  • NVWM LLC first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2020 and held it in 9 quarters.
  • NVWM LLC's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.41M in Q4 2021.
  • 329 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2022.

Based on NVWM LLC's 13F filing for Q2 2022, filed 4 Aug 2022.